Citations

Clear

4847 citation(s) found for "Tu, Eric".

O1‐11‐04: CARDIOVASCULAR RISK FACTORS AND THEIR INTERACTIONS AMONG CLINICALLY DEFINED NEURODEGENERATIVE DISEASES
Malek‐Ahmadi, Michael , Monsell, Sarah E. , Woodruff, Bryan K. , Reiman, Eric M. , Wilson, Jeffrey R. , Dugger, Brittany N. , Kukull, Walter A.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2014.04.119 Get It

P4‐298: IMPROVING THE POWER TO TRACK FIBRILLAR AMYLOID PET MEASUREMENTS AND EVALUATE AMYLOID‐MODIFYING TREATMENTS USING A CEREBRAL WHITE MATTER REFERENCE REGION‐OF‐INTEREST
Roontiva, Auttawut, Lee, Wendy , Ayutyanont, Napatkamon , Protas, Hillary , Landau, Susan , Luo, Ji , Bauer, Robert, Reschke, Cole, Bandy, Dan, Fleisher, Adam , Caselli, Richard J., Jagust, William J. , Weiner, Michael W. , Reiman, Eric M. , Chen, Kewei , Thiyyagura, Pradeep , Liu, Xiaofen , Koeppe, Robert A. , Caselli, Richard J.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2014.07.069 Get It

P2‐141: BRAIN‐DERIVED NEUROTROPHIC FACTOR (BDNF) POLYMORPHISMS ARE ASSOCIATED WITH DIFFERENTIAL RATES OF AMYLOID ACCUMULATION AND COGNITIVE DECLINE IN COGNITIVELY NORMAL OLDER ADULTS
Acosta, Jazmin I., Fleisher, Adam , Reschke, Cole, Bauer, Robert, Caselli, Richard J., Weiner, Michael W. , Reiman, Eric M. , Geda, Yonas E. , Stokin, Gorazd B. , Thiyyagura, Pradeep , Lu, Bai , Caselli, Richard J. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2014.05.816 Get It

First Reported Case of Ehrlichia ewingii Involving Human Bone Marrow
Allen, Mr, Pritt, Bobbi S. , Sloan, Lynne M., Paddock, Christopher D. , Musham, Chaitanya K., Ramos, Jeanette M., Cetin, Neslihan, Rosenbaum, Eric , Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | September 4, 2014 | Volume: 52 | Issue: 11 | Pages: 4102-4104

10.1128/jcm.01670-14 | PMID 25187638 Get It

ABSTRACT A 65-year-old female with a history of multiple tick bites presented with fever and pancytopenia. Intracytoplasmic rickettsial morulae were detected on peripheral smear and bone marrow biopsy specimens, and PCR amplified Ehrlichia ewingii DNA from both specimens. To our knowledge, this is the first report of E. ewingii infection of human bone marrow.
Shape expressions
Prud’hommeaux, Eric , Gayo, José Emilio Labra , Solbrig, Harold R.

Mayo Clinic

Proceedings of the 10th International Conference on Semantic Systems | September 2, 2014 | Volume: No volume available | Issue: No issue available | Pages: 32-40

10.1145/2660517.2660523 Get It

Comprehensive Assessment of Genetic Variants WithinTCF4in Fuchs' Endothelial Corneal Dystrophy
Wieben, Eric D. , Aleff, Ross A., Eckloff, Bruce W., Atkinson, Elizabeth J. , Baheti, Saurabh , Middha, Sumit , Brown, William L. , Patel, Sanjay V. , Kocher, Jean‐Pierre , Baratz, Keith H. , Patel, Sanjay V

Mayo Clinic

Investigative Opthalmology & Visual Science | August 29, 2014 | Volume: 55 | Issue: 9 | Pages: 6101

10.1167/iovs.14-14958 | PMID 25168903 Get It

Sensitivity and specificity of diagnostic ultrasound in the diagnosis of phrenic neuropathy
Boon, Andrea J. , Sekiguchi, Hiroshi , Harper, Caitlin J., Strommen, Jeffrey A., Ghahfarokhi, Leili Shahgholi, Watson, James C. , Sorenson, Eric J. , Ghahfarokhi, Leili S

Mayo Clinic

Neurology | August 28, 2014 | Volume: 83 | Issue: 14 | Pages: 1264-1270

10.1212/wnl.0000000000000841 | PMID 25165390 Get It

Buprenorphine for Cancer Pain
Prommer, Eric

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | August 28, 2014 | Volume: 32 | Issue: 8 | Pages: 881-889

10.1177/1049909114547227 | PMID 25163678 Get It

Buprenorphine (BUP) is a semisynthetic derivative of the opium alkaloid thebaine found in the poppy Papaver somniferum. Its chemical structure contains the morphine structure but differs by having a cyclopropylmethyl group. Buprenorphine is a potent µ opioid agonist. Buprenorphine undergoes extensive first-pass metabolism in the liver and gut. The development of a transdermal BUP formulation in 2001 led to its evaluation in cancer pain. This article provides the practitioner with an update on the current role of BUP in cancer care. It highlights data suggesting effectiveness in various types of cancer pain. The article reviews pharmacology, routes of administration, adverse effects, drug interactions, and cost considerations.
Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11 C-Choline Positron Emission Tomography/Computerized Tomography
Karnes, R. Jeffrey , Bergstralh, Eric J., Dimonte, Guy , Cheville, John C. , Lowe, Val J. , Mynderse, Lance A. , Kwon, Eugene D., Murphy, Christopher R, Murphy, Christopher Raymond

Mayo Clinic

Journal of Urology | August 20, 2014 | Volume: 193 | Issue: 1 | Pages: 111-116

10.1016/j.juro.2014.08.082 | PMID 25150640 Get It

Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta‐analysis
Ungprasert, Patompong , Srivali, Narat , Wijarnpreecha, Karn , Cheungpasitporn, Wisit , Knight, Eric L., Thongprayoon, Charat , Cheungpasitporn, Wisit , Srivali, Narat , Wijarnpreecha, Karn

Mayo Clinic

Respirology | August 19, 2014 | Volume: 19 | Issue: 7 | Pages: 993-998

10.1111/resp.12369 | PMID 25138430 Get It

AbstractA possible causal relationship between sarcoidosis and malignancy has been the subject of debates for decades. To better understand this association, we conducted a systematic review and meta‐analysis of cohort studies that reported relative risk, hazard ratio or standardized incidence ratio with 95% confidence interval (CI) comparing the incidence of malignancy in patients with sarcoidosis versus non‐sarcoidosis participants. Pooled risk ratios (RR) and 95% CI were calculated using a random‐effect, generic inverse variance methodology. Five studies were identified and included in our data analyses. The pooled RR of malignancy in patients with sarcoidosis was 1.21 (95% CI: 1.04–1.40). However, when we performed a sensitivity analysis that included only studies that compared the incidence of malignancy after the first year of the diagnosis of sarcoidosis with the incidence of malignancy after the first year of index date for non‐sarcoidosis controls, the pooled risk ratio decreased and did not reach statistical significance (RR 1.13, 95% CI: 0.97–1.32). Furthermore, analysis for publication bias has suggested that publication bias in favour of positive studies may be present. In conclusion, after accounting for possible detection bias and publication bias, there does not appear be a significant association between sarcoidosis and malignancy.